CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
74 hedge funds and large institutions have $110M invested in Cascadian Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 67 → 74 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
74
Holding in Top 10
1
Calls
$2.27M
Puts
$722K
Top Buyers
| 1 | +$6.75M | |
| 2 | +$2.71M | |
| 3 | +$1.76M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$991K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$940K |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$1.96M | |
| 3 | -$1.42M | |
| 4 |
CI
Cowen Inc
New York
|
-$616K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$470K |